New scan spots hidden thyroid tumors that resist standard treatment

NCT ID NCT04927416

First seen Oct 31, 2025 · Last updated May 13, 2026 · Updated 27 times

Summary

This study tests whether a special PET scan using a compound called 68Ga-DOTATATE can better detect thyroid cancer that has spread and is no longer responding to standard radioactive iodine treatment. About 54 adults with metastatic thyroid cancer will receive an injection of the compound and then undergo a PET/CT scan to see if their tumors light up. The goal is to identify which patients have tumors that could potentially be targeted by future treatments, not to treat the cancer itself.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for METASTIC THYROID CANCER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • National Institutes of Health Clinical Center

    RECRUITING

    Bethesda, Maryland, 20892, United States

    Contact Phone: •••-•••-•••• Email: •••••@•••••

Conditions

Explore the condition pages connected to this study.